Early Phase 1 Lung Cancer Trial, Recruiting (NCT05543954)

Early Phase 1 Lung Cancer Trial, Recruiting NCT05543954 Sponsor: Peking Union Medical College Hospital Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05543954 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with lung cancer or are suspected of having lung cancer
People who are able to have two specific types of PET/CT scans (one using a substance called 68Ga-FAPI-RGD, and one using either 18F-FDG, 68Ga-FAPI, or 68Ga-RGD) within a two-week period
People who are willing and able to sign a written consent form

Who may not be able to join:

People who are pregnant
People who are currently breastfeeding
People who have a health condition that, in the view of the trial doctor, could significantly interfere with their ability to participate in the study (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Zhaohui Zhu, MD,PHD, Peking Union Medical College Hospital

Phone: 86+13611093752

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05543954

Sponsor: Peking Union Medical College Hospital

Phase: Early Phase 1

Status: Recruiting

Condition: Lung Cancer

Trial contact: 86+13611093752

More information: https://clinicaltrials.gov/study/NCT05543954

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with lung cancer or are suspected of having lung cancer
People who are able to have two specific types of PET/CT scans (one using a substance called 68Ga-FAPI-RGD, and one using either 18F-FDG, 68Ga-FAPI, or 68Ga-RGD) within a two-week period
People who are willing and able to sign a written consent form

Who may not be able to join:

People who are pregnant
People who are currently breastfeeding
People who have a health condition that, in the view of the trial doctor, could significantly interfere with their ability to participate in the study (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Early Phase 1

Sponsor

Peking Union Medical College Hospital

Registry

ClinicalTrials.gov

Start date

3 September 2022

Est. completion

31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Diagnostic performance1; Diagnostic performance2; Diagnostic performance3

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov